Challenge of treatment de-escalation in inflammatory bowel diseases

被引：0
|
作者：
Reenaers, Catherine [1 ]
Louis, Edouard [1 ]
机构：
[1] Univ Liege, Univ Hosp CHU & GIGA Inst, Liege, Belgium
来源：
GUT | 2025年
关键词：
IBD CLINICAL; INFLIXIMAB; CROHN'S DISEASE; ULCERATIVE COLITIS; CROHNS-DISEASE; OPEN-LABEL; INFLIXIMAB; MULTICENTER; WITHDRAWAL; REMISSION; THERAPY;
D O I：
10.1136/gutjnl-2024-334358
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Escalating de-escalation in breast cancer treatment
    Sacchini, Virgilio
    Norton, Larry
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (02) : 85 - 90
  • [32] Treatment de-escalation in Crohn's disease
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 290 - 290
  • [33] De-escalation treatment of axilla in breast cancer
    Corso, G.
    Galimberti, V.
    Veronesi, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 445 - 446
  • [34] Escalating de-escalation in breast cancer treatment
    Virgilio Sacchini
    Larry Norton
    Breast Cancer Research and Treatment, 2022, 195 : 85 - 90
  • [35] MS treatment de-escalation: review and commentary
    Selmaj, Krzysztof
    Hartung, Hans-Peter
    Mycko, Marcin P.
    Selmaj, Igor
    Cross, Anne H.
    JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6426 - 6438
  • [36] Treatment de-escalation in Crohn's disease
    Louis, Edouard
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (05): : 401 - 401
  • [37] De-escalation of treatment for acute promyelocytic leukaemia?
    Mathews, Vikram
    LANCET HAEMATOLOGY, 2015, 2 (09): : E348 - E349
  • [38] Treatment de-escalation for stage II seminoma
    Georgina E. Wood
    Florence Chamberlain
    Ben Tran
    Ciara Conduit
    Elizabeth Liow
    David L. Nicol
    Jonathan Shamash
    Constantine Alifrangis
    Prabhakar Rajan
    Nature Reviews Urology, 2023, 20 : 502 - 512
  • [39] De-escalation treatment of axilla in breast cancer
    G. Corso
    V. Galimberti
    P. Veronesi
    Clinical and Translational Oncology, 2020, 22 : 445 - 446
  • [40] Long-Term Outcomes of Treatment With and De-Escalation From a Combination of Vedolizumab and Another Biologic or Tofacitinib for Inflammatory Bowel Disease
    Jan, Jenny
    Fudman, David I.
    Llano, Ernesto M.
    Shrestha, Shreeju
    Burstein, Ezra
    Boktor, Moheb
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S737 - S738
12345